🇺🇸 FDA
Patent

US 6696263

PCNA associated cell cycle proteins, compositions and methods of use

expired A61PA61P35/00A61P37/02

Quick answer

US patent 6696263 (PCNA associated cell cycle proteins, compositions and methods of use) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P35/00, A61P37/02, A61P43/00